Killing of tumor cells in vitro by macrophages from mice given injections of squalene-treated cell wall skeleton of Nocardia rubra. 1981

M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma

Peritoneal exudate cells (PEC) harvested from mice after i.p. injection of squalene-treated cell wall skeleton of Nocardia rubra (N. rubra-CWS) demonstrated vigorous cytolytic activity in vitro toward tumor target cells. Fractionation of these PEC by adherence to plastic dishes showed that the cytolytic activity in PEC was associated with an adherent phagocytic cell. Induction of the cytolytic adherent PEC required an optimal dose of 50 micrograms N. rubra-CWS and i.p. injection. Cytolytic activity of N. rubra-CWS-induced adherent PEC was maximal after 5 days and fell steadily thereafter. Susceptible tumor targets included cells syngeneic, allogeneic, and xenogeneic to the effector cell source. In contrast, nonneoplastic xenogeneic cells were not affected by N. rubra-CWS-induced adherent PEC. The effector cells were not found in the spleen or peripheral lymph nodes. In addition, the cytolytic activity of N. rubra-CWS-induced adherent PEC was completely inhibited by treatment with antimacrophage serum and complement or carrageenan. Treatment with monoclonal anti-Thy 1.2 antibody and complement, however, did not affect the cytolytic activity of the adherent PEC. These features make it likely that N. rubra-CWS-induced cytolytic effector cells are macrophages.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell

Related Publications

M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
October 1978, Gan,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
May 1987, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
November 2022, Current issues in molecular biology,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
January 1988, International journal of immunopharmacology,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
March 1984, The Journal of antibiotics,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
April 1979, Gan,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
November 1986, Arzneimittel-Forschung,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
April 1987, Cancer research,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
April 1986, Cancer research,
M Ito, and H Iizuka, and T Masuno, and R Yasunami, and T Ogura, and Y Yamamura, and I Azuma
May 1979, Cancer research,
Copied contents to your clipboard!